Company Filing History:
Years Active: 2021-2025
Title: Inventor Spotlight: Timothy W. Phares
Introduction
Timothy W. Phares is an innovative inventor based in Reston, Virginia, who has made significant contributions to the field of biotechnology. With a total of six patents to his name, Phares has focused on developing therapeutic peptides with various applications, particularly in the realm of immunology and cancer treatment.
Latest Patents
Phares is renowned for his latest patents, which include:
1. **LAG3 binding peptides** - This patent discloses nucleic acids that encode peptides capable of binding to LAG3. These peptides have the potential to block interactions with other critical molecules such as MHC-II, FGL1, and α-synuclein. Their therapeutic applications are vast, being utilized to inhibit the progression of hyperproliferative disorders, notably cancer, as well as addressing synucleinopathies, sepsis, and infectious diseases. Furthermore, they may enhance the body's response to vaccines.
2. **Immunomodulatory peptides** - This patent describes peptides that serve multiple therapeutic purposes. They can be effective in the treatment of hyperproliferative disorders, infectious diseases, and sepsis, as well as in enhancing vaccination responses. Additionally, these peptides hold promise for promoting hair re-pigmentation and lightening pigmented skin lesions.
Career Highlights
Timothy W. Phares is currently affiliated with Leidos, Inc., a notable company in the field of scientific research and development. Throughout his career, Phares has demonstrated a strong commitment to innovation, particularly in creating solutions that can address complex medical challenges.
Collaborations
In his endeavors, Phares collaborates with other talented professionals, including Gabriel M. Gutierrez and James Pannucci. Their collective expertise contributes to enhancing the quality and impact of the inventions being developed.
Conclusion
Timothy W. Phares exemplifies the spirit of innovation within the biotechnology sector. With his impressive portfolio of patents and collaborative efforts, he continues to make strides in therapeutic advancements that have the potential to change lives for the better.